Cited by 52Pituitary Gland Disorders and TreatmentsTraumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances

Post-Traumatic Hypopituitarism—Who Should Be Screened, When, and How?

Open access
Quinn, Mark, Agha, Amar·2018·Frontiers in Endocrinology

Abstract

Traumatic brain injury (TBI) remains a major, global public health concern. Over the last 15 years, a significant body of evidence has emerged demonstrating that post-traumatic hypopituitarism (PTHP) is a common and clinically significant consequence of TBI. Non-specific symptomology and the lack of an agreed approach to screening for PTHP has led to significant under-diagnosis of this debilitating disease. In this review, we will discuss the frequency and clinical significance of acute and chronic PTHP as described in the current literature highlighting the evidence base for screening and hormone replacement in these patients. We will also offer a pragmatic approach to identifying relevant anterior pituitary dysfunction after TBI and a follow-up strategy for those patients. Specific controversies and remaining unanswered questions will be addressed.

AI snapshot

Written from the paper’s full text.

TL;DR

Post-traumatic hypopituitarism (PTHP) is a common and clinically significant complication of moderate-to-severe traumatic brain injury (TBI), but it remains underdiagnosed because symptoms are nonspecific and screening approaches are not standardized. This review summarizes the evidence and offers a pragmatic approach to screening and hormone replacement, focusing on acute ACTH-cortisol deficiency and later assessment of adrenal, thyroid, gonadal, and GH axes.

Key findings

  • TBI incidence is estimated at 134–618 persons per 100,000 per year, with highest incidence in adult men; a meta-analysis of 19 studies reported a pooled PTHP prevalence of 27%.
  • GH deficiency appears to be the commonest pituitary hormone deficiency when patients are tested 6 months or more after TBI; acute-phase abnormalities are most clinically significant for ACTH-cortisol deficiency and salt/water imbalance, with one acute study reporting ACTH deficiency in 78% and diabetes insipidus in 51%.
  • Acute cortisol below 300 nmol/l is suggestive of adrenal insufficiency and glucocorticoid treatment should be instituted; levels of 300–500 nmol/l should be interpreted in clinical context.
  • The authors recommend screening patients with moderate or severe TBI, not routinely screening mild TBI unless specific symptoms suggest hypopituitarism, and considering selected “complicated” mild TBI cases; chronic assessment is usually at 3–6 months, with GH assessment deferred until 1 year post-TBI.

Methods

  • Narrative review of the current literature on acute and chronic PTHP after TBI, including a summary table of main studies assessing PTHP frequency.
  • The review synthesizes evidence on epidemiology, pathophysiology, clinical significance, screening candidates, and timing of endocrine assessment.
  • It proposes a pragmatic screening and management algorithm, including serial morning cortisol in the acute phase and dynamic testing such as the corticotrophin test for chronic adrenal assessment.

Limitations

  • The paper states that data for mild TBI and hypopituitarism are limited, the relationship between TBI severity and PTHP remains controversial, and there is currently no evidence to support treating acute GH, thyroid hormone, gonadotropin deficiencies, or hyperprolactinemia.
  • The paper states that randomized clinical trials examining GH replacement in post-traumatic GH deficiency are needed.
  • Evident from the text: as a narrative review, no systematic search strategy, quality appraisal, or pooled analysis is described; reported PTHP frequencies vary due to patient selection, timing of testing, and methodological heterogeneity, and screening recommendations for complicated mild TBI have considerable resource implications.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fendo.2018.00008

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

8 of 37 cited sources checked · 3 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    PTHP is correlated with decreased exercise capacity.

    “as well as decreased exercise capacity (30)”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [30] Mossberg, 2008, Aerobic capacity and growth hormone deficiency after traumatic brain injury, J Clin Endocrinol Metab source

      The Results report significantly lower peak oxygen consumption in patients with traumatic brain injury and GH insufficiency or deficiency than in those with a normal GH response. This supports an association with reduced exercise capacity for post-traumatic GH dysfunction, but the study does not establish the claim for post-traumatic hypopituitarism (PTHP) generally. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Premisecitation

    In one well-executed study, the frequency of PTHP after simple mild TBI was found to be very low.

    “In one well-executed study, the frequency of PTHP after simple mild TBI was found to be very low (22).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [22] van der Eerden, 2010, Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury?, Eur J Endocrinol source

      The Abstract (p. 2) reports only one case of anterior pituitary dysfunction among 107 patients, including 77 with mild TBI; the Discussion (p. 9) says none of the 30 moderate/severe patients had dysfunction. This supports a very low frequency in the studied mild-TBI patients, but the paper does not report a separate frequency for “simple” or uncomplicated mild TBI. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation

    The most robust data on incidence of PTHP are in patients with moderate or severe TBI.

    “The most robust data with regard to incidence of PTHP are in those patients with moderate or severe TBI (14).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [14] Agha, 2004, Anterior pituitary dysfunction in survivors of traumatic brain injury, J Clin Endocrinol Metab source

      The Discussion (page unavailable) calls this the largest study to date of anterior pituitary function after TBI and says it studied a large group of moderate or severe TBI survivors. This supports the claim that substantial evidence comes from that group, but the paper reports prevalence among survivors, not incidence, and does not establish that these are the most robust data compared with data for mild TBI. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation

    Early GH deficiency post TBI can be transient.

    “Early GH deficiency post TBI can be transient (36).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [36] Agha, 2005, The natural history of post-traumatic hypopituitarism: implications for assessment and treatment, Am J Med source
  • Premisecitation

    Numerous retrospective and prospective studies show a high rate of PTHP among long-term survivors of TBI.

    “However, over the last 15 years, there has been numerous retrospective and prospective studies showing a high rate of PTHP among long-term survivors of TBI (Table 1).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Table 1

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims. 12
  • Classified as probably not a substantial claim. 1
  • May combine two claims.

    Premisecitation

    Some early pituitary abnormalities are transient and recover fully within days or weeks after TBI, while new pituitary hormone deficiency may become apparent in the post-acute phase.

    “Some of these early abnormalities are transient and recover fully within days or weeks after TBI while new pituitary hormone deficiency may become apparent in the post-acute phase (13, 14).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [13] Schneider, 2006, Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury, Eur J Endocrinol source
    • cites [14] Agha, 2004, Anterior pituitary dysfunction in survivors of traumatic brain injury, J Clin Endocrinol Metab source

      The Discussion (page unavailable) says early hormone deficiencies may spontaneously recover, but describes their natural history as largely unknown; it does not establish full recovery within days or weeks. The Methods report testing survivors 6–36 months after injury, but the paper does not show that new deficiencies emerged in the post-acute phase. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Data on the relationship between CT findings and PTHP are limited, with one study demonstrating a correlation between diffuse brain swelling and PTHP and another finding no such association.

    “The data on this is limited with one study demonstrating a correlation between diffuse brain swelling and PTHP (19) and another finding no such association (14).”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [19] Kelly, 2000, Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report, J Neurosurg source
    • cites [14] Agha, 2004, Anterior pituitary dysfunction in survivors of traumatic brain injury, J Clin Endocrinol Metab source
  • May combine two claims.

    Premisecitation

    Some studies showed a significant association between mild TBI and hypopituitarism, while one large study showed a very low incidence of PTHP in mild TBI cases.

    “While some studies showed a significant association (21), one excellent large study showed a very low incidence of PTHP in mild TBI cases (22).”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [21] Tanriverdi, 2010, Pituitary function in subjects with mild traumatic brain injury: a review of literature and proposal of a screening strategy, Pituitary source
    • cites [22] van der Eerden, 2010, Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury?, Eur J Endocrinol source
  • May combine two claims.

    Premisecitation

    PTHP is correlated with unfavorable metabolic and body composition profiles and lower quality of life scores.

    “Other studies have found a correlation between PTHP and unfavorable metabolic and body composition profiles with associated lower quality of life scores (28, 29)”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [28] Klose, 2007, Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury, J Clin Endocrinol Metab source
    • cites [29] Mossberg, 2017, Functional changes after recombinant human growth hormone replacement in patients with chronic traumatic brain injury and abnormal growth hormone secretion journal of neurotrauma, J Neurotrauma source

      The Introduction (page unavailable) reports that a prior study found decreased quality of life in TBI patients with growth hormone deficiency and also describes reduced muscle mass in people with growth hormone deficiency. It does not establish the claimed correlation between post-traumatic hypopituitarism, unfavorable metabolic and body-composition profiles, and lower quality-of-life scores; this study assessed changes after growth hormone replacement without a GH-sufficient TBI comparison group. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Interpretationnone given

    Non-specific symptomology and the lack of an agreed approach to screening for PTHP has led to significant under-diagnosis of PTHP.

    “Non-specific symptomology and the lack of an agreed approach to screening for PTHP has led to significant under-diagnosis of this debilitating disease.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    PTHP can masquerade as post-concussional syndrome and can be overlooked, leading to delayed recovery and impaired rehabilitation.

    “PTHP can masquerade as a post-concussional syndrome and can be overlooked leading to delayed recovery and impaired rehabilitation (5).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [5] Ropper, 2007, Concussion, N Engl J Med source
  • May combine two claims.

    Premisenone given

    The GCS is limited by significant inter-observer variability and scores can fluctuate over time.

    “In patients with moderate or severe TBI, the scores do not seem to predict the risk of PTHP (8) but it is important to emphasize that this scale is limited by significant inter-observer variability and that the GCS scores can fluctuate over time.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    Post-traumatic hypopituitarism (PTHP) is a common and clinically significant consequence of traumatic brain injury (TBI).

    “Over the last 15 years, a significant body of evidence has emerged demonstrating that post-traumatic hypopituitarism (PTHP) is a common and clinically significant consequence of TBI.”
    • Also stated in: § Introduction · boosted
      “Over the recent 15 years, numerous research studies have documented a high rate of pituitary gland dysfunction following moderate or severe TBI with evidence that post-traumatic hypopituitarism (PTHP) contributes significantly to the morbidity and possibly mortality in those patients (4).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [4] Park, 2010, Anterior pituitary dysfunction in moderate-to-severe chronic traumatic brain injury patients and the influence on functional outcome, Brain Inj source
  • May combine two claims.

    Interpretationcitation

    Vascular injury is likely the commonest mechanism of pituitary damage after TBI, as autopsy studies have demonstrated pituitary infarction in up to 43% of fatal TBI cases.

    “It is likely that a vascular injury is the commonest mechanism as autopsy studies have demonstrated pituitary infarction in up to 43% of cases of fatal TBI (20).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [20] Salehi, 2007, Histologic study of the human pituitary gland in acute traumatic brain injury, Brain Inj source
  • May combine two claims.

    Interpretationnone given

    Dynamic tests of the adrenal axis (insulin stress test or corticotrophin test) are either inappropriate or unreliable in the acute setting of TBI.

    “However, these dynamic tests are either inappropriate (the insulin stress test) or unreliable (the corticotrophin test) in the acute setting of TBI.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Features that seem to confer increased risk of PTHP include diffuse axonal injury on brain imaging, prolonged ICU admission, basal skull fracture, and increasing age.

    “Features that seem to confer an increased risk of PTHP include diffuse axonal injury on brain imaging, prolonged admission to ICU, basal skull fracture, and increasing age (32).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [32] Schneider, 2008, Predictors of anterior pituitary insufficiency after traumatic brain injury, Clin Endocrinol source
  • May combine two claims.

    Interpretationnone given

    PTHP is now recognized as a common, but often underdiagnosed, complication which may contribute significantly to morbidity and possibly mortality following moderate and severe TBI.

    “PTHP is now recognized as a common, but often underdiagnosed, complication which may contribute significantly to the morbidity and possibly the mortality following moderate and severe TBI.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Early detection and treatment of PTHP improves clinical outcomes.
  • May combine two claims.

    Premisecitation

    Acute-phase cortisol deficiency in TBI is potentially life threatening and is associated with increased morbidity and mortality.

    “In patients with TBI, acute-phase cortisol deficiency is potentially life threatening and a number of studies have shown an association between increased morbidity and mortality in acute post-traumatic hypoadrenalism (11, 23).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [11] Hannon, 2013, Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality, J Clin Endocrinol Metab source
    • cites [23] Cohan, 2005, Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study*, Crit Care Med source
13 of 13
  • The paper relies on this without support.

    Early detection and treatment of PTHP improves clinical outcomes.

    “Therefore, screening patients for PTHP should be an important part of the standard care provided following severe or moderate TBI.”
  • The paper relies on this without support.

    Treatment of acute cortisol deficiency reduces mortality or morbidity in TBI patients.

    “An acute-phase cortisol level below 300 nmol/l is suggestive of adrenal insufficiency (34) and treatment with glucocorticoids should be instituted (Figure 1).”
  • The paper relies on this without support.

    Hormone replacement for chronic pituitary deficiencies improves outcomes.

    “If a deficiency is detected, we recommend replacement as appropriate and repeating the assessment at 1 year as early deficiencies may recover (36).”
  • The paper relies on this without support.

    Screening complicated mild TBI is beneficial.

    “Therefore, selected cases of complicated mild TBI could also be offered screening but this will clearly have considerable resource implications.”
4 of 4

Cites

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Cyran, 1918, Hypophysenschädigung durch Schädelbasisfraktur, Dtsch Med Wochenschr, 44, 1261

Cited by

Sorted by citations

Authors
Quinn, M., & Agha, A.
Affiliations
Royal College of Surgeons in Ireland (IE)
Venue
Frontiers in Endocrinology
Published
2018-02-02
Volume
9
Pages
8-8
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2792730153
Cited by
52
References
39
Citations by year
2026: 6 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 8 · 2019: 9 · 2018: 1
FWCI
3.60
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
post-traumatic hypopituitarism, traumatic brain injury, anterior pituitary dysfunction, screening, hormone replacement therapy, underdiagnosis, follow-up strategy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-14.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-14.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review